Multicenter Mpact DM France

Recruiting Observational Study
Total Hip Arthroplasty Survival, Prosthesis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
600 (estimated)
Sponsor
Medacta International SA · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty. The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patient with a disease that meets the indications for use of Medacta implants (according to the instructions for use) 2. Patient eligible for first-line total hip replacement 3. Patient between 18 and 80 years of age 4. Patient covered by the Social Security system or an equi…
Contacts

Arianna Girardi

+41 91 696 60 60

girardi@medacta.ch

CONTACT